Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects

By Nunes Teresa  

Drugs in R&D, Vol. 10, Iss. 4, 2010-11 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

Single‐ and multiple‐dose pharmacokinetics of tofacitinib in healthy Chinese volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 395-399

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐ and multiple‐dose pharmacokinetics of tofacitinib in healthy Chinese volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 395-399

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection

By Cahn Pedro  

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 129-138

Adis International

Access to resources Recommend Favorite

A Phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers

By Lee Hae Won   Lim Mi-sun   Seong Sook Jin   Lee Joomi   Park Jeonghyeon   Seo Jeong Ju   Yun Hwi-yeol   Baek In-hwan   Kwon Kwang-il   Yoon Young-Ran  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1471-1479

Informa Healthcare

Access to resources Recommend Favorite